Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Pulmonary function in patients surviving to COVID-19 pneumonia
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
title
Pulmonary function in patients surviving to COVID-19 pneumonia
Creator
Daniela, ·
Borsa, Noemi
Colombo, Daniele
Corsonello, Andrea
Fumagalli, Alessia
Lattanzio, Fabrizia
Limonta, Simone
Misuraca, Clementina
Soraci, Luca
Bianchi, ·
Bonardi, Rita
Mirko, ·
Rosa, Di
Sveva Maggiolini, ·
source
Medline; PMC
abstract
PURPOSE: The aim of our study was to assess respiratory function at the time of clinical recovery and 6 weeks after discharge in patients surviving to COVID-19 pneumonia. METHODS: Our case series consisted of 13 patients with COVID-19 pneumonia. RESULTS: At the time of clinical recovery, FEV1 (2.07 ± 0.72 L) and FVC (2.25 ± 0.86 L) were lower compared to lower limit of normality (LLN) values (2.56 ± 0.53 L, p = 0.004, and 3.31 ± 0.65 L, p < 0.001, respectively), while FEV1/FVC (0.94 ± 0.07) was higher compared to upper limit of normality (ULN) values (0.89 ± 0.01, p = 0.029). After 6 weeks pulmonary function improved but FVC was still lower than ULN (2.87 ± 0.81, p = 0.014). CONCLUSION: These findings suggest that COVID-19 pneumonia may result in clinically relevant alterations in pulmonary function tests, with a mainly restrictive pattern. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s15010-020-01474-9) contains supplementary material, which is available to authorized users.
has issue date
2020-07-28
(
xsd:dateTime
)
bibo:doi
10.1007/s15010-020-01474-9
bibo:pmid
32725597
has license
no-cc
sha1sum (hex)
7244f44c758433dcd4c50caf256a097b4d192ee0
schema:url
https://doi.org/10.1007/s15010-020-01474-9
resource representing a document's title
Pulmonary function in patients surviving to COVID-19 pneumonia
has PubMed Central identifier
PMC7386387
has PubMed identifier
32725597
schema:publication
Infection
resource representing a document's body
covid:7244f44c758433dcd4c50caf256a097b4d192ee0#body_text
is
schema:about
of
named entity 'discharge'
named entity 'COVID-19'
named entity 'FVC'
named entity 'patients'
named entity 'CLINICAL'
named entity 'FVC'
named entity 'normality'
named entity 'Results'
named entity 'pneumonia'
named entity 'pneumonia'
named entity 'weeks'
named entity 'case series'
named entity 'FVC'
named entity 'FEV1/FVC'
named entity 'pneumonia'
named entity 'respiratory function'
named entity 'lung function'
named entity 'acute phase'
named entity 'Pulmonary function tests'
named entity 'pulmonary function tests'
named entity 'COVID-19'
named entity 'fever'
named entity 'life-threatening'
named entity 'FVC'
named entity 'ground glass opacities'
named entity 'droplet'
named entity 'hypoxemia'
named entity 'respiratory rehabilitation'
named entity 'pneumonia'
named entity 'comorbidities'
named entity 'signs and symptoms'
named entity 'PCR'
named entity 'BMI'
named entity 'pulmonary function'
named entity 'COVID-19'
named entity 'polymerase chain reaction'
named entity 'sequelae'
named entity 'Fever'
named entity 'clinically relevant'
named entity 'respiratory rehabilitation'
named entity 'chest X-ray'
named entity 'FEV'
named entity 'infectious disease'
named entity 'SPSS'
named entity 'COVID'
named entity 'high-resolution computed tomography'
named entity 'pulmonary function'
named entity 'work-up'
named entity 'quality of life'
named entity 'pulmonary function tests'
named entity 'C-reactive protein'
named entity 'fatigue'
named entity 'pneumology'
named entity 'FEV'
named entity 'COVID-19'
named entity 'pneumonia'
named entity 'Switzerland'
named entity 'Roche'
named entity 'infection'
named entity 'Arterial blood gases'
named entity 'pulmonary function tests'
named entity 'blood gas analysis'
named entity 'arterial blood gas'
named entity 'FEV'
named entity 'pulse oximetry'
named entity 'COVID'
named entity 'Pulmonary function tests'
named entity 'FEV'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 4
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software